PUBLISHER: The Business Research Company | PRODUCT CODE: 1653117
PUBLISHER: The Business Research Company | PRODUCT CODE: 1653117
Mucosal atomization devices are designed to administer medication through the nostrils, ensuring reliable topical solution atomization across the nasal and oropharyngeal mucous membranes. These devices are particularly effective in delivering atomized medication to mucosal surfaces in the nasal, oral, laryngeal, tracheal, and lung regions.
The primary types of mucosal atomization devices include nasal atomization devices, fibre-optic atomization devices, laryngotracheal atomization devices, and bottle atomizer devices. Nasal atomization devices provide a painless and safe method for swiftly delivering fast-acting drugs that efficiently penetrate mucosal membranes and enter the bloodstream. Various mucosal atomization device technologies include gas-propelled atomization devices and electrical atomization devices. These devices find application in diverse healthcare settings, including hospitals, ambulatory surgical centers, and specialized clinics.
The mucosal atomization devices market research report is one of a series of new reports from The Business Research Company that provides mucosal atomization devices market statistics, including mucosal atomization devices industry global market size, regional shares, competitors with an mucosal atomization devices market share, detailed mucosal atomization devices market segments, market trends and opportunities, and any further data you may need to thrive in the mucosal atomization devices industry. This mucosal atomization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The mucosal atomization devices market size has grown strongly in recent years. It will grow from $0.85 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to emergency medicine, anesthesia, pediatric care, pain management, dental procedures.
The mucosal atomization devices market size is expected to see rapid growth in the next few years. It will grow to $1.4 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to chronic diseases, telemedicine, precision medicine, cosmetic procedures, patient comfort, autonomous vehicles. Major trends in the forecast period include sustainable and eco-friendly practices, digital mortuary management, green burial options, remote viewing and streaming services, hybrid funeral services.
The growth of the mucosal atomization devices market is driven by the increasing prevalence of allergic rhinitis worldwide. Allergic rhinitis, characterized by symptoms affecting the nose due to exposure to allergens like pollen, dust, or animal dander, prompts the use of mucosal atomization devices for chronic rhinosinusitis treatment, delivering budesonide as a topical nasal steroid spray. Seasonal allergic rhinitis, commonly known as hay fever, is a prevalent allergic condition, affecting approximately 7.7% of adults and 7.2% of children in the United States, as reported in the Allergy Capital Report 2022. Consequently, the rising incidence of allergic rhinitis globally contributes to the growth of the mucosal atomization devices market.
The anticipated growth in the elderly population is set to propel the mucosal atomization device market forward. Defined as individuals aged 65 and above, the elderly population is expected to play a significant role in driving the demand for mucosal atomization devices. With aging, susceptibility to chronic conditions such as allergic rhinitis and sinusitis increases, necessitating the use of mucosal atomization devices for treatment. Data from America's Health Rankings indicates that in the United States, over 56 million adults aged 65 and above constitute around 16.9% of the total population. The projection of more than 73.1 million older individuals by 2030, as the baby boomer generation ages, further emphasizes the role of the elderly population in fueling the mucosal atomization device market.
Major companies in the mortuary equipment market are embracing a strategic partnership approach to advance nasal powder delivery device technology. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in November 2023, Hovione, a Portugal-based provider of services for pharmaceutical drug development and manufacturing, teamed up with Industrial Design Consultancy (IDC), a UK-based product design and development firm. The goal of this partnership is to create an innovative nasal powder delivery device technology that enables local, systemic, and nose-to-brain drug delivery. These devices are designed to provide broad and targeted nasal deposition flexibility, ensuring maximum usability and reliability.
Major companies in the mucosal atomization device market are concentrating on developing technological advancements such as metal-free nasal spray pumps to enhance the patient experience. For example, in January 2023, Aptar Pharma, a US-based pharmaceutical company, introduced the APF Futurity. This metal-free, multidose nasal spray pump is designed for delivering nasal saline and similar over-the-counter (OTC) formulations. The APF Futurity is Aptar Pharma's first highly recyclable nasal spray pump, having received a Class AA certification from cyclos-HTP for recycling in Europe. Constructed from polyolefin materials without any metal components or recycling disruptors, the APF Futurity reduces separation efforts in recycling streams and supports the production of higher quality recyclates.
In March 2022, Kurve Technology Inc., a US-based company specializing in the development of liquid drug delivery devices, merged with Savile Therapeutics Inc. This merger provides Kurve Technology access to the assets of Savile Therapeutics Inc., fostering further growth and expansion. Savile Therapeutics Inc. is a US-based medical device company.
Major companies operating in the mucosal atomization devices market include Teleflex Incorporated, DeVilbiss Healthcare LLC, Becton Dickinson and Company, Cook Medical LLC, Medica Holdings LLC, Life-Assist Inc., Pulmodyne Inc., Alcove Manufacturing and Distribution Inc., LMA North America Inc., Medline Industries Inc., Medtronic plc, Smiths Medical Inc., Vyaire Medical Inc., Westmed Inc., Mercury Medical, SunMed LLC, Salter Labs, Armstrong Medical Industries Inc., VBM Medizintechnik GmbH, Intersurgical Ltd., Flexicare Medical Limited, Medovations Inc., Medisize BV, Atom Medical Corporation, BLS Systems Limited, Central Admixture Pharmacy Services Inc., Dali Medical Devices Co. Ltd., Dynarex Corporation
North America was the largest region in the mucosal atomization devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mucosal atomization devices market growth report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the mucosal atomization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
The mucosal atomization devices market consists of sales of 3cc Syringe and VetJet. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mucosal Atomization Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mucosal atomization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for mucosal atomization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mucosal atomization devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.